Correlation of Hepatic Uptake with Fatty Liver |
An, Young-Sil
(Department of Nuclear Medicine and Molecular Imaging, Ajou University School of medicine)
Yoon, Joon-Kee (Department of Nuclear Medicine and Molecular Imaging, Ajou University School of medicine) Hong, Seon-Pyo (Department of Nuclear Medicine and Molecular Imaging, Ajou University School of medicine) Joh, Chul-Woo (Department of Nuclear Medicine and Molecular Imaging, Ajou University School of medicine) Yoon, Seok-Nam (Department of Nuclear Medicine and Molecular Imaging, Ajou University School of medicine) |
1 | Kurtaran A, Becherer A, Pfeffel F, Muller C, Traub T, Schmaljohann J, et al.-fluorodeoxyglucose (FDG)-PET features of focal nodular hyperplasia (FNH) of the liver. Liver 2000;20: 487-90 DOI ScienceOn |
2 | Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116: 1413-9 DOI ScienceOn |
3 | Day CP, James OF. Steatohepatitis: a tale of two 'hits'? Gastroenterology 1998;114:842-5 DOI ScienceOn |
4 | Dam-Larsen S, Franzmann M, Andersen IB, Christoffersen P, Jensen LB, Sorensen TI, et aI. Long term prognosis of fatty liver: risk of chronic liver disease and death. Gut 2004;53:750-5 DOI |
5 | Savolainen VT, Liesto K, Mannikko A, Penttila A, Karhunen PJ. Alcohol consumption and alcoholic liver disease: evidence of a threshold level of effects of ethanol. Alcohol Clin Exp Res 1993;17:1112-7 DOI ScienceOn |
6 | Chen CH, Huang MH, Yang JC, Nien CK, Yang CC, Yeh YH et al. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults. J Clin Gastroenterol 2006;40:745-52 DOI ScienceOn |
7 | Teli MR, James OF, Burt AD, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 1995;22:1714-9 DOI |
8 | Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994;107:1103-9 DOI |
9 | Harrison SA, Diehl AM. Fat and the liver: a molecular overview. Semin Gastrointest Dis 2002;13:3-16 |
10 | Delbeke D, Martin WH, Sandler MP, Chapman WC, Wright JK Jr, Pinson CW. Evaluation of benign vs. malignant hepatic lesions with positron emission tomography. Arch Surg 1998;133:510-5 DOI ScienceOn |
11 | Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003;37:1202-9 DOI ScienceOn |
12 | Teli MR, James OF, Burt AD, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 1995;22:1714-9 DOI |
13 | Kim CK, Gupta NC. Dependency of standardized uptake values of fluorine-18 fluorodeoxyglucose on body size: comparison of body surface area correction and lean body mass correction. Nucl Med Commun 1996;17:890-4 DOI ScienceOn |
14 | Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004;40:1387-95 DOI ScienceOn |
15 | Goldberg MA, Lee MJ, Fischman AJ, Mueller PR, Alpert NM, Thrall JH. Fluorodeoxyglucose PET of abdominal and pelvic neoplasms: potential role in oncologic imaging. Radiographics 1993;13:1047-62 DOI |
16 | Kaneta T, Hakamatsuka T, Takanami K, Yamada T, Takase K, Sato A, et al. Evaluation of the relationship between physiological FDG uptake in the heart and age, blood glucose level, fasting period, and hospitalization. Ann Nucl Med 2006;20:203-8 DOI |
17 | de Groot M, Meeuwis AP, Kok PJ, Corstens FH, Oyen WJ. Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut. Eur J Nucl Med Mol Imaging 2005;32:98-101 DOI ScienceOn |
18 | Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992;33:1972-80 |
19 | Jimba S, Nakagami T, Takahashi M, Wakamatsu T, Hirota Y, Iwamoto Y, et al. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet Med 2005;22:1141-5 DOI ScienceOn |
20 | Haque M, Sanyal AJ. The metabolic abnormalities associated with non-alcoholic fatty liver disease. Best Pract Res Clin Gastroenterol 2002;16:709-31 DOI ScienceOn |